¸ŁŔűĽ§

24 February 2025

LiU-researcher Frank Hernandez has received a grant for his research in designing antibiotics that can be administered with precision. It is one of 23 approved grants by The Swedish Research Council (VR) that focuses on antimicrobial resistance.

Frank Hernandez, Baris Borsa, Anna Carolina Lenhart

His project is developing a new class of drugs based on precision medicine principles. These drugs are designed to target specific organs or tissues, enhancing therapeutic efficacy while minimizing side effects.
“The technology can be used to treat localized infections, such as skin and soft tissue infections, osteomyelitis, endocarditis, and pneumonia, says Frank Hernandez”

The goal is to complete the preclinical phase for an experimental antibiotic and initiate first-in-human studies to bring this innovative technology closer to clinical use.
"This project represents the second phase of our TOUCAN platform development."

TOUCAN Technology, a company co-founded by Frank Hernandez and soon transferred to Theralia AB, integrates conventional drugs with a nano-transport system for targeted delivery. Like a GPS it identifies bacterial infections within the body, delivering treatment with high precision, efficacy, and minimal side effects.
“The nano-transport is a short nucleic acid (e.g., DNA) carrying the drug. It remains inactive in the blood and only activates upon detecting a bacterial infection, releasing the drug to kill bacteria. This makes the drug harmless and safer for other parts of the body. In short, the drug works only where it's needed.”

Although demonstrated in bacterial infections, this approach has potential applications for treating conditions such as cancer and autoimmune diseases.
“The ultimate goal of this project is to begin the validation of TOUCAN technology in human clinical trials through the development of the first targeted antibiotics. Once the pre-clinical phase is completed, we will validate the safety features of the TOUCAN technology in humans, followed by its application in treating infections using this technology”, says Frank Hernandez.


Contact

Latest news from LiU

En kvinna står i snön framför ett batterilager.

The battle for power – who has the right to our electricity?

Wind farms rising like the Eiffel Tower, data centres consuming as much power as entire regions and municipalities feeling like pawns in a global game. The large-scale investments  are creating conflict:  who has priority access to our electricity?

A man and a woman shaking hands in front of a statue.

New AI partnership strengthens the region

The AI Academy Partnership Program at ¸ŁŔűĽ§ will support companies and organisations in developing the skills needed to use AI effectively. The first partner in this new form of collaboration is Länsförsäkringar Östgöta.

En grupp människor står på ett trädäck.

Molecular medicine research secures long-term funding

The Wallenberg Centre for Molecular Medicine (WCMM) at LiU has been granted extended funding until 2039 by the Knut and Alice Wallenberg Foundation. This makes it possible to build on ten years of success and to recruit new physician-scientists.